Clinical Trial Update: Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating prasterone for vulvovaginal atrophy in postmenopausal women with vulvar/vestibular pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Atrophy

Drugs mentioned

• Prasterone (dehydroepiandrosterone (DHEA))

Snippet

Sponsor: Dr. Santiago Palacios | Conditions: Vulvovaginal Atrophy | Phase 3 | Status: UNKNOWN